I consider the 3 FTDs as significant derisking and couldn’t have come from any another intelligent and independent source than the FDA itself! Leaving the SP aside, from a FA perspective they have effectively said - both Cu64 and 67 works! Let us help you bring this to market to plus the unmet need, increase safety and efficacy and increase early detection and cure.
The delays are there which the mgmt isn’t being open and transparent about but that doesn’t diminish the drugs’ clinical effectiveness.
If anything I think the IIT head-to-head trial should once and for all prove who is the boss in today’s radio pharma industry. M&A may follow that. Looking forward to it.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)